Brief: Vivos Inc. Strengthens Strategic Collaboration With Exubrion Therapeutics
29/10/2025 14:22
Vivos Inc RDGL.PK: VIVOS INC. STRENGTHENS STRATEGIC COLLABORATION WITH EXUBRION THERAPEUTICS Source text: ID:nGNX7LhGkx Further company coverage: RDGL.PK
Recent news on Vivos
See all newsBrief: Vivos Inc. Announces Progress Toward FDA Investigational Device Exemption (Ide) Submission
Brief: Vivos Inc. Strengthens Strategic Collaboration With Exubrion Therapeutics
Brief: Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., To Support Ide Submission For Radiogel®
Brief: Vivos Board Authorizes To Establish A Corporate Entity In India
Brief: Vivos Inc. Achieves Record Growth In IsoPet® Animal Cancer Treatments In Q1 2025